mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
0.9 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
1 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
1 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |